The practical utility of an economic analysis of calcineurin withdrawal following renal transplantation.
Kaplan
Bruce
B
Schold
Jesse D
JD
D065095:Calcineurin Inhibitors; D003362:Cost-Benefit Analysis; D004791:Enzyme Inhibitors / Q000008:administration & dosage*; D006801:Humans; D007165:Immunosuppression Therapy / Q000191:economics*; D016030:Kidney Transplantation / Q000276:immunology*; D018803:Models, Economic
D065095:Calcineurin Inhibitors; D004791:Enzyme Inhibitors